Evidence map›Paper›PMID 42273784›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Vulnerability of the locus coeruleus-entorhinal cortex white matter tract in autosomal dominant Alzheimer's disease.

Elouise A Koops, Averi Giudicessi, Ana Baena, Lusiana Martinez, Nikole Bonillas-Felix, Randy Medrano, Joyita Dutta, Isabela Gonzalez, Sergio Alvarez, David Aguillon and 2 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elouise A KoopsThe Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-4105-4254
Averi GiudicessiDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ana BaenaGrupo de Neurociencias de Antioquia, Universidad de Antioquia, Medellín, Antioquia, Colombia.
Lusiana MartinezDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Nikole Bonillas-FelixDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Randy MedranoDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Joyita DuttaDepartment of Biomedical Engineering, University of Massachusetts Amherst, Amherst, Massachusetts, USA.
Isabela GonzalezDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Sergio AlvarezDepartment of Radiology, Hospital Pablo Tobón Uribe, Medellín, Antioquia, Colombia.
David AguillonGrupo de Neurociencias de Antioquia, Universidad de Antioquia, Medellín, Antioquia, Colombia.
Yakeel T QuirozDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Heidi I L JacobsThe Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Funding

Tracking the origin of tau pathology: dovetailing (pre-)preclinical biomarker trajectoriesR01AG062559 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Heidi Irma Jacobs · 2019 to 2026
$4.8M
The wandering nerve: gateway to boost Alzheimer's disease related cognitive performanceR01AG068062 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI JACOBS, HEIDI IRMA · 2021 to 2025
$4.6M
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's diseaseR01AG054671 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI QUIROZ, YAKEEL T. · 2017 to 2021
$3.8M
Locus coeruleus network architecture of Alzheimer's disease vulnerabilityR01AG082006 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Heidi Irma Jacobs, Jorge Sepulcre · 2023 to 2026
$2.7M
Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's diseaseRF1AG077627 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI AGUILLON, DAVID FERNANDO, CUELLO, A CLAUDIO · 2022 to 2022
$2.0M
Elevated locus coeruleus metabolism as mechanism driving Alzheimer's disease pathologyR21AG074220 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI JACOBS, HEIDI IRMA · 2021 to 2022
$477k
Examining Sex-Specific Effects on White Matter Integrity and Brain Function in Familial Alzheimer's Disease and Vascular DementiaF31NS134277 · NINDS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI Averi Jordin Giudicessi · 2024 to 2026
$129k
Alzheimer's Association 23AARF-1026796Massachusetts General Hospital (MGH) Executive Committee on ResearchNIA NIH HHS R01 AG054671NIA NIH HHS R01AG054671NIA NIH HHS R01 AG062559NIA NIH HHS R01AG062559NIA NIH HHS R01 AG068062NIA NIH HHS R01AG068062NIA NIH HHS R01 AG082006NIA NIH HHS R01AG082006NIA NIH HHS R21 AG074220NIA NIH HHS R21AG074220NIA NIH HHS RF1 AG077627NIA NIH HHS RF1AG077627NINDS NIH HHS 1F31NS134277-01A1NINDS NIH HHS F31 NS134277
6 · The paper itself

Abstract

introductionLocus coeruleus (LC) structural integrity declines early in sporadic and autosomal dominant Alzheimer's disease (AD). We examined LC-entorhinal cortex (LC-EC) tract integrity and its association with amyloid and tau pathology and memory in autosomal dominant AD (ADAD).

methodsWe examined associations between diffusion-weighted imaging-derived LC-EC tract characteristics and age, sex, amyloid (Pittsburgh Compound B [PiB]), entorhinal tau ([

resultsLC-EC tract integrity was lower in females and older individuals in both non-carriers and carriers. In mutation carriers, lower tract integrity was associated with higher entorhinal tau and poorer memory, with tau and amyloid mediating the tract-memory relationship in the entire sample but not in unimpaired carriers. DISCUSSION: These findings highlight the LC-EC tract as an early disease vulnerability marker in ADAD, with tract disruption associated with memory decline across disease stages, a relationship further mediated by entorhinal tau pathology as disease progresses.

Indexed as

Alzheimer DiseaseEntorhinal CortexLocus CoeruleusWhite MatterAgedAniline CompoundsDiffusion Magnetic Resonance ImagingFemaleHumansMaleMiddle AgedMutationPositron-Emission TomographyPresenilin-1tau ProteinsThiazolesAniline CompoundsPresenilin-1PSEN1 protein, humantau ProteinsThiazolesautosomal dominant Alzheimer's disease (ADAD)diffusion weighted imaging (DWI)entorhinal cortexflortaucipir (FTP)locus coeruleusmagnetic resonance imaging (MRI)Pittsburg Compound B (PiB)preclinicalpresenilin‐1

Identifiers

PMID42273784
PMCPMC13254689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.